NCT07037498

Brief Summary

The goal of this clinical trial is to learn whether a locally developed supplement called MRJ - a combination of Moringa oleifera (drumstick tree) extract and royal jelly - can improve the nutritional status and cognitive function of adolescent girls more effectively than standard iron and folic acid (IFA) tablets. The main questions it aims to answer are: Does MRJ supplementation lead to better improvements in nutrition (e.g., hemoglobin, body measurements)? Does MRJ supplementation enhance cognitive function compared to IFA tablets? Researchers will compare MRJ capsules to IFA tablets (the standard of care) among adolescent girls. Participants will: Take 2 MRJ capsules per week (intervention group) or 1 IFA tablet per week (control group) for 12 months Receive nutrition education via short TikTok-based videos Have their adherence monitored weekly by teachers and through WhatsApp photos Measurements will be taken at the start, 6 months, and 12 months, including: Height, weight, and mid-upper arm circumference (MUAC) Hemoglobin levels via finger-prick blood test Dietary intake using a 24-hour recall and food frequency questionnaire (FFQ) Cognitive function assessed with the Culture Fair Intelligence Test (CFIT) Participants are healthy junior and senior high school girls aged 10-18 years from Galesong Selatan, Takalar District, South Sulawesi, Indonesia. Potential side effects (e.g., nausea or stomach discomfort) will be monitored according to school health protocols. The findings may support the use of culturally appropriate, nutrient-rich interventions for improving adolescent girls' health and future well-being.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
372

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

June 17, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 25, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2026

Completed
Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

4 months

First QC Date

June 17, 2025

Last Update Submit

August 7, 2025

Conditions

Keywords

Nutrition

Outcome Measures

Primary Outcomes (1)

  • Change in Body Mass Index-for-Age Z-score (BMI-for-age)

    Mean change in BMI-for-age z-scores as per WHO AnthroPlus standards, measured at baseline, 6 months, and 12 months.

    Baseline, 6 months, and 12 months

Secondary Outcomes (2)

  • Change in Mid-Upper Arm Circumference (MUAC)

    Baseline, 6 months, and 12 months

  • Change in cognitive function score (CFIT)

    Baseline and 12 months

Study Arms (2)

MRJ Supplementation Group

EXPERIMENTAL

Participants in this arm receive MRJ capsules containing 490 mg Moringa oleifera extract and 10 mg royal jelly, taken twice per week for 12 months. The supplementation is accompanied by standardized nutrition education delivered through TikTok videos. Adherence is monitored weekly via teacher-supervised log sheets and WhatsApp documentation.

Dietary Supplement: Moringa Oleifera

IFA Tablet Group (Control)

ACTIVE COMPARATOR

Participants in this arm receive weekly iron-folic acid (IFA) tablets according to national guidelines (60 mg elemental iron and 400 µg folic acid) for 12 months. They also receive the same standardized nutrition education via TikTok videos. Adherence is tracked using weekly log sheets verified by teachers and supported by WhatsApp photo submissions.

Dietary Supplement: Moringa Oleifera

Interventions

Moringa OleiferaDIETARY_SUPPLEMENT

Participants receive MRJ capsules containing 490 mg of Moringa oleifera leaf extract and 10 mg of royal jelly, taken orally twice per week for 12 months. The capsules are plant-based, produced using locally sourced ingredients, and are part of a food-based supplementation strategy developed as an alternative to iron-folic acid tablets. The intervention is combined with standardized nutrition education via TikTok videos. Adherence is monitored weekly through teacher log sheets and WhatsApp documentation. and Participants receive iron-folic acid (IFA) tablets containing 60 mg of elemental iron and 400 µg of folic acid, taken orally once per week for 12 months in accordance with Indonesia's national supplementation guidelines for adolescent girls. This control intervention is combined with the same standardized nutrition education via TikTok videos. Compliance is tracked weekly through teacher-supervised control sheets and WhatsApp photo submissions.

Also known as: Royal jelly, edukasi
IFA Tablet Group (Control)MRJ Supplementation Group

Eligibility Criteria

Age12 Years - 19 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • (1) Age 10-19 years (2) Adolescent girls' who are active in grades 1 and 2 (junior high and senior high)

You may not qualify if:

  • (3) Severe nutritional or health conditions (e.g., severe anemia, severe malnutrition, allergies), determined through clinical histories and validated self-reports.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schools under the supervision of Puskesmas Bonto Kassi, Galesong Selatan, Takalar District, South Sulawesi, Indonesia

Takalar, South Sulawesi, 92254, Indonesia

Location

Related Publications (1)

  • 1. Patton GC, Sawyer SM, Santelli JS, et al. Our future: a Lancet commission on adolescent health and wellbeing. Lancet. 2016;387(10036):2423-78. 2. World Health Organization. Nutrition in adolescence: issues and challenges for the health sector. Geneva: WHO; 2005. 3. Black MM. Micronutrient deficiencies and cognitive functioning. J Nutr. 2003;133(11 Suppl 2):3927S-31S. 4. Best C, Neufingerl N, Van Geel L, van den Briel T, Osendarp S. The nutritional status of school-aged children: why should we care? Food Nutr Bull. 2010;31(3):400-17. 5. UNICEF. The State of the World's Children 2019: Children, food and nutrition. New York: UNICEF; 2019. 6. World Health Organization. Anaemia in women and children. Geneva: WHO; 2023. 7. Health Research and Development Agency. Basic Health Research 2018. Jakarta: Ministry of Health, Republic of Indonesia; 2018. 8. Ministry of Health of the Republic of Indonesia. Indonesia Health Profile 2023. Jakarta: MoH; 2024. 9. Dewey KG, Begum K. Long-term consequences of stunting in early life. Matern Child Nutr. 2011;7(Suppl 3):5-18. 10. Hadju V, Salmah AU, Natsir R, et al. Stunting and its risk factors among adolescent girls in South Sulawesi. Media Gizi Masyarakat Indonesia. 2020;5(2):59-66. 11. Walker SP, Chang SM, Powell CA, et al. Effects of early childhood psychosocial stimulation and nutritional supplementation on cognition and education in growth-stunted Jamaican children. Lancet. 2005;366(9499):1804-7. 12. Grantham-McGregor S, Cheung YB, Cueto S, et al. Developmental potential in the first 5 years for children in developing countries. Lancet. 2007;369(9555):60-70. 13. Prentice AM, Ward KA, Goldberg GR, et al. Critical windows for nutritional interventions against stunting. Am J Clin Nutr. 2013;97(5):911-8. 14. Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull. 2003;24(4 Suppl):S99-103. 15. Ministry of Health of the Republic of Indonesia. Indonesia Nutrition Status Survey (SSGI) 2023. Jakarta: MoH; 2024.

    RESULT

MeSH Terms

Conditions

MalnutritionAnemiaGrowth Disorders

Interventions

flocculant protein MO 2.1, Moringa oleiferaroyal jelly

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesHematologic DiseasesHemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Nutrition

Study Record Dates

First Submitted

June 17, 2025

First Posted

June 25, 2025

Study Start

February 10, 2025

Primary Completion

June 10, 2025

Study Completion

February 17, 2026

Last Updated

August 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) that will be shared include de-identified data on anthropometric measures (BMI-for-age, height-for-age, MUAC), hemoglobin levels, dietary intake (24-hour recall and FFQ), and cognitive function scores (CFIT results). All shared data will be anonymized and stripped of any personal identifiers.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The de-identified individual participant data (IPD) will be available beginning 6 months after publication of the primary results and will remain available for up to 5 years thereafter.
Access Criteria
Qualified researchers with a scientifically sound proposal may request access to the de-identified data. Access will be granted for purposes of academic research, meta-analysis, or systematic review. Requests should be submitted in writing to the principal investigator or sponsor institution and must include a data use agreement.

Locations